FDA panel rejects MDMA-based treatment for PTSD
Source: @BreaknNews
USA TODAY - For more and to sign up click here Nick Robertson A potential treatment for post-traumatic stress disorder using the psychedelic MDMA was overwhelmingly rejected by a panel of federal regulators on Tuesday, marking what could be a major setback for the use of psychedelics in the treatment of mental illness. The Food and Drug Administration (FDA) panel voted 10-1 against endorsing the safety of MDMA in…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at @BreaknNews